Skip to main content
Premium Trial:

Request an Annual Quote

Roche Wins Contract for HPV Screening in Sweden

This article has been corrected to state that Roche's test detects 14 high-risk HPV types, rather than 13 as originally reported.

NEW YORK (GenomeWeb News) – Roche today announced it has been awarded an exclusive contract by Karolinska University Hospital to provide its cobas HPV Test as a primary screening tool for human papillomavirus in women in Sweden.

The agreement is the first major public tender in Europe for use of Roche's test to screen women for high-risk HPV types that may lead to cervical cancer, the company said. It added that the screening program, which will start in November, is expected to serve as a pilot program for nationwide implementation of HPV primary screening in Sweden.

The cobas HPV Test is a qualitative in vitro test and uses PCR and nucleic acid hybridization to amplify target DNA to detect 14 high-risk HPV types. Specifically, it identifies types HPV 16 and HPV 18 — the two highest-risk HPV genotypes, responsible for more than 70 percent of cervical cancers cases — as well as other high-risk types.

The test is available in the US and in countries accepting the CE mark and runs on Roche's cobas 4800 system.

According to Roche, guidelines issued by the European Union in 2008 introduced the possibility of using HPV testing as the primary diagnostic test for cervical screening, and Sweden is one of the first nations to follow those guidelines.

Daniel O'Day, COO of Roche Diagnostics, said that the company has shown that in clinical trials 10 percent of women with normal Pap results and with HPV genotype 16 and/or HPV genotype 18 already had pre-cancerous lesions. These women may not receive follow-up care.

"With the introduction of our new HPV test as the primary screening test, we hope to reduce the number of women who are missed in the early stages, and thereby enable earlier intervention before they develop cervical cancer," O'Day said.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.